Blog - Page 528 of 5683 - QualityStocks

WednesdayMar 20, 2024 1:11 pm

QualityStocksNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Eko2o S.A.S Eyes Expansion into Costa Rica and Central America

Eko2o S.A.S., a leader in sustainable agricultural technologies and a majority-owned subsidiary of Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), today announced its strategic plans to expand operations into Costa Rica and the broader Central American market. The initiative aligns with Eko2o’s mission to promote sustainable agriculture and innovative technology solutions around the globe. “Costa Rica and Central America are regions known for their commitment to environmental sustainability and high agricultural potential. This makes them the perfect match for Eko2o’s mission and expertise,” said Juan Ricardo Velez, CEO of Eko2o. “We are excited about the opportunity to collaborate with local…

WednesdayMar 20, 2024 1:03 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Announces Leading PR Firm as Official Communications and Marketing Agency of Record

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, has selected Counsel Public Affairs as its communications and marketing agency of record; the two companies entered into an initial 12-month agreement. According to the announcement, FuelPositive conducted a thorough search and selected Counsel for its reputation as Canada’s most effective public affairs firm and because of its specialization in government relations, strategic communications and integrated campaigns. In addition to PR support, Counsel will provide investor relations communications support. “We are thrilled to welcome Counsel Public Affairs as our newly appointed agency of record,” said FuelPositive chief impact officer Luna…

WednesdayMar 20, 2024 12:54 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into definitive agreements. The agreements are for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) of the company and warrants to purchase up to 1,542,112 shares of common stock; the stocks and warrants are offered at a combined price of $4.215 per share of common stock (or per prefunded warrant in lieu thereof) and accompanying warrant. Genprex will be receive approximately $6.5 million in gross proceeds from the offering, before standard fees and…

WednesdayMar 20, 2024 12:28 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split of the company’s Class A common stock. The move was approved by the company’s board of directors during a special stockholder meeting. According to the announcement, the reverse split will become effective at 11:59 p.m. ET on March 26, 2024. Following that, the company’s Class A common stock will begin trading on the NASDAQ Capital Market on a split-adjusted basis. “The reverse split is intended to increase the per share trading price of the company’s common stock to enable the…

WednesdayMar 20, 2024 12:27 pm

QualityStocksNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, recently expanded its therapeutic candidates, introducing ImmunePrep(TM) to improve the delivery of immunotherapeutic antibodies to treat cancer. “The company is also developing ChemoPrep(TM) and ChemoPure(TM) to optimize chemotherapy delivery and reduce treatment toxicity. The company further disclosed that clinical site locations for first-in-human studies for Sigyn Therapy(TM) have been identified. Sigyn Therapy(TM) is a novel blood purification technology to treat pathogen-associated conditions that are beyond the reach of drugs,” a recent article reads. “Sigyn Therapeutics is developing innovative medical technologies to address critical healthcare challenges. The company’s technologies show promise in…

WednesdayMar 20, 2024 9:45 am

Life Electric Vehicles Holdings Inc. (LFEV) Is ‘One to Watch’

Life EV Group in December 2023 announced its acquisition of a 40% interest in LEV Manufacturing through a share exchange LEV Manufacturing Inc. in July 2023 acquired Serial 1 Cycle Company, an e-bike maker founded by Harley-Davidson In February 2022, the company announced a name change to Life Electric Vehicles Holdings Inc. In November 2021, Second Street Capital Inc. merged with Life Electric Vehicles Holdings Inc. Life Electric Vehicles Holdings (OTC: LFEV) (d/b/a Life EV Group), along with its subsidiaries, is a developer, manufacturer and distributor in the light electric vehicle industry. The company’s business model focuses on the launch,…

WednesdayMar 20, 2024 9:00 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils New E-Boat Model, Names New CFO in Preparation for Industry Growth

The global electric boats market is forecast to more than double in size, increasing from $3.3 billion in 2023 to $7.7 billion by 2030 Vision Marine’s unveiling of its newest e-boat offering, the Phantom, couldn’t have come at more opportune time The company’s new chief financial officer brings invaluable expertise and insight in manufacturing, production and delivery As the electric boat sector is projected to double in value in the next few years, companies operating in the industry are positioning themselves to meet — and even exceed — the expectations this growth could create. For example, Vision Marine Technologies (NASDAQ:…

TuesdayMar 19, 2024 3:22 pm

QualityStocksNewsBreaks – SOBR Safe Inc.’s (NASDAQ: SOBR) Alcohol Detection Technology Poised to Improve Workplace Safety and Behavioral Outcomes

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”) has developed a patent-pending alcohol detection device to detect alcohol in humans with just a single touch of the finger. “SOBRsafe’s alcohol detection technology can improve workplace safety and provide advanced screening and monitoring solutions for the behavioral health industry… SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol through the user’s skin. No breath, blood or urine samples are required – making it a hygienic alternative to traditional breathalyzers,” a recent article reads. “SOBRsafe’s technology is integrated within the company’s robust and scalable platform, producing statistical and measurable user and business…

TuesdayMar 19, 2024 2:49 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Expanding Operations Within Agricultural Sectors

SenesTech (NASDAQ: SNES), a rodent pest control enterprise, has begun to establish a global reach for its innovative Birth Control for Rats(TM) products. “The company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects on food markets. On Jan. 29, SenesTech announced the signing of a distribution agreement with Poppe Enterprises LLC for the grain management market. Poppe Enterprises will be a stocking distributor for SenesTech’s Evolve(TM) soft bait in the outlets it serves in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado, according to the announcement… SenesTech’s Evolve(TM) soft bait delivers…

TuesdayMar 19, 2024 12:26 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 1,542,112 shares of common stock at a combined offering price of $4.215 per share of common stock (or per prefunded warrant in lieu thereof) and accompanying warrant, in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $4.09 per…

Site Search

Company Search